Aurinia Pharmaceuticals Inc. (AUPH) Deep Dive Video
Summary
Aurinia combines a profitable, high-margin lupus nephritis franchise with underappreciated autoimmune pipeline optionality, creating an asymmetric value setup if patent defenses hold and clinical catalysts mature.